Drug intelligence / Profile preview

EpriGard

Development stage
Unknown
Lead developer
Aurora Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

EpriGard is a veterinary antiparasitic topical solution developed and marketed by Aurora Pharmaceutical. Its active ingredient is eprinomectin, a small molecule belonging to the macrocyclic lactone class. EpriGard is primarily indicated for the treatment and control of internal and external parasites in beef and dairy cattle, including gastrointestinal roundworms, lungworms, grubs, lice, mange mites, and horn flies. It is characterized by its high potency and the convenience of a zero-day withdrawal period for both meat and milk in cattle. Although primarily recognized as a bovine product, Aurora Pharmaceutical categorizes it within its poultry product line on its commercial website, suggesting its application or relevance in avian parasite management.

Brand names
EpriGard
Other names
eprinomectin
02

Targets

GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)GluCl (Glutamate-gated chloride channel)

Beyond the preview

Go deeper on EpriGard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EpriGard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call